Stemtech Corporation (OTCPK:STEK) entered into a letter of intent to acquire Life Factor Research on August 29, 2022. As of October 25, 2022, Stemtech Corporation entered into a definitive agreement to acquire Life Factor Research. Life Factor Research will act as the division responsible for research and development and product formulations.

Stemtech Corporation (OTCPK:STEK) completed the acquisition of Life Factor Research for $7.9 million in March 2023. As per the terms of the transaction, 2.4 million shares was issued by STEK.